Development and production of parenteral dosage forms for clinical studies

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200900006C
Awardee
Awarding agency
Obligated
$2,751,568

Award facts

Opportunity
Contract value 22% obligated
  • $8,407,381.25 Current, with exercised options
  • $12,563,944.25 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN16 R&D- Medical: Biomedical (Management/Support)
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Bedford, OH 44146, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 18 · Modified to deobligate uninvoiced monies that remained in the contract after contract closure -$3,027
Close Out 19 · Modified to deobligate funds that remained in contract after contract closure -$8,041
Other Administrative Action 17 · This modification modifies articles b.2., b.3., f.1., and g.4. To extend the period of performance and authorize property transfer. $0
Other Administrative Action 16 · This modification modifies article b.3. To allow data sharing as specified on the following page. $0
Other Administrative Action 15 · This modification modifies articles b.2. And f.1. To reduce contract value to actuals and delete options. $0
Funding Only Action 14 · This modification modifies articles b.3. To provide funding for change order. $10,000
Other Administrative Action 13 · This modification modifies articles b.3. Advanced understanding to cancel project 13-302 and to provide additional funding for change order under project… -$195,639
Funding Only Action 12 · This modification modifies article b.3. Advanced understandings to reflect a new project (13-303)needed for patients. $207,630
Other Administrative Action 11 · This modification adds contract title and period of performance to header text box to be in compliance with most recent guidance. $0
Funding Only Action 10 · This modification adds two project orders as described in article b.3. $489,100
Other Administrative Action 9 · Other functions ; revising sections g and i to reflect hhsar clause updates and provide additional OFM invoicing instructions. $0
Other Administrative Action 8 · ; administratively adding advanced understanding is article b.3. $0
Funding Only Action 7 $685,000
Funding Only Action 6 $92,544
Funding Only Action 5 $340,000
Funding Only Action 4 $150,000
Funding Only Action 3 $200,000
Supplemental Agreement for work within scope 2 $0
Other Administrative Action 1 · Biomedical (management/support) $0
Original award $784,000
Show all 20

Quick answers

Who was awarded contract HHSN261200900006C?

HHSN261200900006C was awarded to Ben Venue Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on December 31, 2008.

How much is contract HHSN261200900006C worth?

The government has obligated $2,751,568 on HHSN261200900006C. Its current value, with exercised options, is $8,407,381. Its potential value, with all options, is $12,563,944.

Was contract HHSN261200900006C competed?

The extent of competition for HHSN261200900006C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login